Quality of Life in Growth Hormone Treated Adults

Abstract

We surveyed the quality of life of adult patients with growth hormone (GH) deficiency, who ceased GH therapy before the age of 20. We sent quetionnaires to 1, 116 patients and their physicians concerning their socio-economic status and medical background. Return rates were 64% and 69%, respectively. The final height was above -2 standard deviation in 61% of the patients. The distribution of occupation and income were quite similar to those in the general population. Patients with a final adult height below 155cm in males or below 140cm in females felt a disadvantage in getting jobs and in finding marriage partners. The CMI revealed slight psychological problems in these patients.